Status:
COMPLETED
Effect of Arista Powder on Bleeding in Reductive Mammary Surgery
Lead Sponsor:
University of Oslo
Collaborating Sponsors:
Ullevaal University Hospital
Medafor
Conditions:
Mammaplasty
Eligibility:
FEMALE
Phase:
PHASE2
Brief Summary
To evaluate whether Arista AH which contains microporous polysaccharides used as a powder applied to the wound area during mammary surgery reduces the amount of bleeding and the duration of surgery. B...
Detailed Description
During the operation,before the first incision a randomization envelope is opened. Always starts on the same side, with or without Arista according to the envelope. After surgery, vacuum drains are pl...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All women for mammary hypertrophy day surgery. No exclusions in this group.
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00227084
Start Date
September 1 2005
End Date
October 1 2006
Last Update
August 27 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ulleval University Hospital
Oslo, Norway, N-0407 Oslo